# A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.

> **NCT00042718** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 659 (actual)

## Conditions studied

- Bronchitis
- Chronic Bronchitis

## Interventions

- **DRUG:** levofloxacin, azithromycin, amoxicillin/clavulanate

## Key facts

- **NCT ID:** NCT00042718
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2010-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042718, "A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00042718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*